Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
57.19 USD | +5.93% | +20.96% | -6.10% |
15/07 | TD Cowen Adjusts Legend Biotech Price Target to $67 From $71, Maintains Buy Rating | MT |
04/07 | Genscript Biotech's Phase 3 Multiple Myeloma Drug Trial Yields Positive Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.10% | 9.84B | |
+21.24% | 127B | |
+23.91% | 117B | |
+26.40% | 27.67B | |
-19.65% | 20.33B | |
-15.99% | 16.79B | |
-18.19% | 15.63B | |
+13.44% | 14.84B | |
-47.70% | 14.65B | |
+58.66% | 14.43B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- TD Cowen Adjusts Legend Biotech Price Target to $67 From $71, Maintains Buy Rating